KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) has very high prevalence and associated-mortality. However, targeted therapies that are currently used in clinical practice for HCC have certain limitations, in part because of the lack of reliable and clinically applicable biomarkers that can be used for d...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Lei, Zhang, Wenfa, Zou, Fagui, Mei, Lihua, Wu, Gang, Teng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073891/
https://www.ncbi.nlm.nih.gov/pubmed/27769251
http://dx.doi.org/10.1186/s12885-016-2851-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073891/
https://www.ncbi.nlm.nih.gov/pubmed/27769251
http://dx.doi.org/10.1186/s12885-016-2851-7

Ejemplares similares